CClinicalTrials.gg
Sign In
Status unknownNCT05663632Updated Dec 23, 2022

Triglyceride-Glucose Index In Heart Failure Patients In Sohag University Hospital

An observational study in Heart Failure and Insulin Resistance, sponsored by Sohag University. Status unknown at 1 site in Egypt. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2022-12-23.

Sponsored by Sohag University · Observational

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
200
Ages
19 Years and older
Sex
All
01

Study summary

study the relationship between Triglyceride glucose index and heart failure patients

02

Conditions studied

  • Heart Failure
  • Insulin Resistance

Keywords

  • heart failure
  • triglyceride-glucose index
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 200 is close to the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients will be divided into2 groups, as following:

Group (1) Heart Failure patients (100 patients) Group (2) control group(100 person)

All groups will be subjected to :

  1. Complete history taking with special emphasis on Age ,Sex, Smoking, Diabetes mellitus and Hypertension.
  2. A thorough clinical examination will stress on:

1- Heart rate (b.p.m.). 2-Systolic BP (mmHg). 3-BMI calculated as the ( weight (kg)/height (m)2). 3-The following investigations will be done to every subject:

  1. FBG (mg/dL)
  2. FTG, (mg/dL)
  3. Total cholesterol (TC) (mg/dL)
  4. SCr (mg/dL)
  5. Echocardiography

TyG index is calculated as ln [fasting triglyceride (mg/dL) * fasting glucose (mg/dL) / 2]

Inclusion criteria

  • All Heart Failure patients attend to sohag university hospital aged above 18 year old .

Exclusion criteria

Exclusion Criteria:

  • Patients on lipid lowering medications
  • Patients on antidiabetic drugs
  • Patients with comorbidities eg liver cirrhosis or malignancy
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • group 1 heart failure patients
  • Group 2 controle
06

What researchers measure

Primary outcomes

  1. Triglyceride-Glucose Index in Heart Failure Patients

    identify the relationship between Triglyceride-Glucose Index and heart failure patients in Sohag University hospital

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Sohag University Hospital
    Sohag, Egypt
    • Magdy M Amin, professor · Contact
    Recruiting
08

References and documents

Publications

  • GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9. Erratum In: Lancet. 2020 Nov 14;396(10262):1562. doi: 10.1016/S0140-6736(20)32226-1. PubMed 33069326 ↗
  • Davison B, Cotter G. Why is heart failure so important in the 21st century? Eur J Heart Fail. 2015 Feb;17(2):122-4. doi: 10.1002/ejhf.219. Epub 2014 Dec 30. No abstract available. PubMed 25557121 ↗
  • Miller M, Seidler A, Moalemi A, Pearson TA. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol. 1998 May;31(6):1252-7. doi: 10.1016/s0735-1097(98)00083-7. PubMed 9581716 ↗
  • Shaye K, Amir T, Shlomo S, Yechezkel S. Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J. 2012 Jul;164(1):111-6. doi: 10.1016/j.ahj.2012.03.023. PubMed 22795290 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05663632
Lead sponsor
Sohag University
Responsible party
Aliaa Khairy Shabaan (resident at internal medicine department, Sohag University) — Principal investigator
First posted
Dec 23, 2022
Start date
Dec 12, 2022
Primary completion
May 2023 (estimated)
Completion
Jun 2023 (estimated)
Last update
Dec 23, 2022

Study contacts

Aliaa k Khyry, resident doctor
Contact
aliaakhairy@med.sohag.edu.eg
01067655291
Ali T Taha, professor
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Heart Failure→

Other studies from this sponsor

Sohag University

Start the discussion